Coagulation Abnormalities in a Prospective Cohort of 50 Patients with PMM2-Congenital Disorder of Glycosylation
Diederik De Graef(Mayo Clinic in Florida), Éva Morava(Institut thématique Génétique, génomique et bioinformatique), Christin Johnsen(University of Göttingen), Kaitlin Schwartz(Mayo Clinic in Florida), Anna N. Ligezka(Mayo Clinic in Florida), Graeme Preston(Mayo Clinic), Gina L. Mazza(Mayo Clinic in Arizona), Tamás Kozicz(Mayo Clinic in Florida), Wirginia Krzyściak(Jagiellonian University), Christina Lam(Seattle Children's Hospital), Joseph Rezents(Mayo Clinic in Florida), Andrew C. Edmondson(Translational Therapeutics (United States))
Cited by 0
Related Papers
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
|Journal of Clinical Oncology|2023|136
Complicated diverticular disease of the sigmoid colon. An analysis of short and long term outcome in 392 patients.
|PubMed|1979|107
Heterozygosity for a Loss-of-Function Mutation in GALNT2 Improves Plasma Triglyceride Clearance in Man
|Cell Metabolism|2011|100
SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females
|The American Journal of Human Genetics|2021|90